Supernus Pharmaceuticals reported $117.72M in Operating Expenses for its first fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Abbott ABT:US $ 8881M 534M
Adamas Pharmaceuticals ADMS:US 28.84M 7.15M
Aerie Pharmaceuticals AERI:US $ 57.19M 3.09M
Ani Pharmaceuticals ANIP:US $ 51.48M 5.44M
Antares Pharma ATRS:US $ 36.69M 1.34M
Aphria Inc APH:CN C$ 221.95M 18.21M
Bristol Myers Squibb BMY:US $ 9.99B 666M
Canopy Growth Corp WEED:CN C$ 381.01M 325.13M
Cara Therapeutics CARA:US $ 25.5M 8.3M
Corcept Therapeutics CORT:US $ 59.64M 154K
Eisai 4523:JP Y 153535M 4141M
Eli Lilly And LLY:US $ 5650.3M 202.4M
Endo International Ordinary Shares ENDP:US $ 535.24M 94.12M
Gw Pharmaceuticals GWPH:US 173.49M 2.46M
Horizon Pharma HZNP:US $ 502.42M 2.82M
JAZZ PHA JAZZ:US $ 445.46M 46.64M
Lannett LCI:US $ 109.52M 241M
Marinus Pharmaceuticals MRNS:US $ 28.97M 9.92M
Pacira Pharmaceuticals PCRX:US $ 99.59M 12.6M
Perrigo Ordinary Shares PRGO:US $ 958.6M 383.1M
Pfizer PFE:US $ 13063M 3998M
Revance Therapeutics RVNC:US $ 83.31M 5.79M
Supernus Pharmaceuticals SUPN:US $ 117.72M 17.16M
Teva Pharmaceutical Industries TEVA:US 3.33B 220M
United Therapeutics UTHR:US $ 443.9M 124.3M
Xeris Pharmaceuticals Inc XERS:US $ 24.94M 1.58M